250 related articles for article (PubMed ID: 34422088)
1. Radiomics Analysis Based on Automatic Image Segmentation of DCE-MRI for Predicting Triple-Negative and Nontriple-Negative Breast Cancer.
Ma M; Gan L; Jiang Y; Qin N; Li C; Zhang Y; Wang X
Comput Math Methods Med; 2021; 2021():2140465. PubMed ID: 34422088
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of triple negative breast cancer based on DCE-MRI multi-phase full-volume ROI clinical radiomics model.
Qi X; Wang W; Pan S; Liu G; Xia L; Duan S; He Y
Acta Radiol; 2024 Feb; 65(2):173-184. PubMed ID: 38017694
[TBL] [Abstract][Full Text] [Related]
3. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
Ma M; Gan L; Liu Y; Jiang Y; Xin L; Liu Y; Qin N; Cheng Y; Liu Q; Xu L; Zhang Y; Wang X; Zhang X; Ye J; Wang X
Eur J Radiol; 2022 Jan; 146():110095. PubMed ID: 34890936
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of radiomics technology based on X-ray mammography in patients with triple-negative breast cancer.
Zhang HX; Sun ZQ; Cheng YG; Mao GQ
J Xray Sci Technol; 2019; 27(3):485-492. PubMed ID: 31081797
[TBL] [Abstract][Full Text] [Related]
5. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
6. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
7. Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study.
Wang J; Kato F; Oyama-Manabe N; Li R; Cui Y; Tha KK; Yamashita H; Kudo K; Shirato H
PLoS One; 2015; 10(11):e0143308. PubMed ID: 26600392
[TBL] [Abstract][Full Text] [Related]
8. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
9. Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.
El Adoui M; Drisis S; Benjelloun M
Int J Comput Assist Radiol Surg; 2020 Sep; 15(9):1491-1500. PubMed ID: 32556920
[TBL] [Abstract][Full Text] [Related]
10. Independent validation of machine learning in diagnosing breast Cancer on magnetic resonance imaging within a single institution.
Ji Y; Li H; Edwards AV; Papaioannou J; Ma W; Liu P; Giger ML
Cancer Imaging; 2019 Sep; 19(1):64. PubMed ID: 31533838
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of triple negative breast cancer based on radiomics signatures extracted from preoperative contrast-enhanced chest computed tomography.
Feng Q; Hu Q; Liu Y; Yang T; Yin Z
BMC Cancer; 2020 Jun; 20(1):579. PubMed ID: 32571245
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Benign and Malignant Breast Lesions on DCE-MRI by Using Radiomics and Deep Learning With Consideration of Peritumor Tissue.
Zhou J; Zhang Y; Chang KT; Lee KE; Wang O; Li J; Lin Y; Pan Z; Chang P; Chow D; Wang M; Su MY
J Magn Reson Imaging; 2020 Mar; 51(3):798-809. PubMed ID: 31675151
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
[TBL] [Abstract][Full Text] [Related]
15. An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies.
Pötsch N; Dietzel M; Kapetas P; Clauser P; Pinker K; Ellmann S; Uder M; Helbich T; Baltzer PAT
Eur Radiol; 2021 Aug; 31(8):5866-5876. PubMed ID: 33744990
[TBL] [Abstract][Full Text] [Related]
16. Identification of triple-negative breast cancer and androgen receptor expression based on histogram and texture analysis of dynamic contrast-enhanced MRI.
Xu WJ; Zheng BJ; Lu J; Liu SY; Li HL
BMC Med Imaging; 2023 Jun; 23(1):70. PubMed ID: 37264313
[TBL] [Abstract][Full Text] [Related]
17. Task-based assessment of a convolutional neural network for segmenting breast lesions for radiomic analysis.
Spuhler KD; Ding J; Liu C; Sun J; Serrano-Sosa M; Moriarty M; Huang C
Magn Reson Med; 2019 Aug; 82(2):786-795. PubMed ID: 30957936
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of peritumoral vascular and intratumoral radiomics to predict pathologic complete responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer.
Xie T; Gong J; Zhao Q; Wu C; Wu S; Peng W; Gu Y
BMC Med Imaging; 2024 Jun; 24(1):136. PubMed ID: 38844842
[TBL] [Abstract][Full Text] [Related]
19. Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer.
Musall BC; Abdelhafez AH; Adrada BE; Candelaria RP; Mohamed RMM; Boge M; Le-Petross H; Arribas E; Lane DL; Spak DA; Leung JWT; Hwang KP; Son JB; Elshafeey NA; Mahmoud HS; Wei P; Sun J; Zhang S; White JB; Ravenberg EE; Litton JK; Damodaran S; Thompson AM; Moulder SL; Yang WT; Pagel MD; Rauch GM; Ma J
J Magn Reson Imaging; 2021 Jul; 54(1):251-260. PubMed ID: 33586845
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
